Not currently recruiting at UC Health
A Study of the Experimental Drug Rogaratinib (BAY1163877) vs Chemotherapy For Urothelial Carcinoma (cancer of the urinary tract)
- for people ages 18 years and up (full criteria)
- at UC Davis
- study startedestimated completion:
Carcinoma, Transitional Cell Urothelial carcinoma Carcinoma Rogaratinib (BAY1163877) Chemotherapy Rogaratinib
- accepting new patients
- Start Date
- Completion Date
- Click here and search for drug information provided by the FDA.
- Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.
- Phase 2/3
- Study Type
- Last Updated
- July 9, 2018